With billions of dollars invested researching and marketing a successful drug, brand-name drug manufacturers are taking a hard-line approach to litigation. The question now facing the industry is whether recent changes to federal regulations involving patents and drugs will bring a truce to the sector or take the fight to a new level.
Additional Info
- Subtitle
Published in
Features
Featured Videos
Latest Videos
-
Former Supreme Court of Canada justice Louise Charron offers lawyers some inside tips on pleading cases before the country's top court and other appellate courts. -
Executive coach Debra Forman discusses where to find relationships and how to build them in order to get more work.
Digital Editions
